Title: SENATE BILL No. 292
Official Title: SENATE BILL No. 292
Number of Sections: 1
Source: versions - As introduced
Media Type: application/pdf
Strikethrough Detection: 16 sections found

================================================================================

Section 1:
Session of 2025
By Committee on Federal and State Affairs
3-6
1 AN ACT concerning industrial hemp; relating to hemp-derived
2 cannabinoid products; prohibiting the transfer of such products to any
3 person under the age of 21; establishing packaging and labeling
4 requirements for such products; amending the definition of industrial
5 hemp and hemp products; amending K.S.A. 2-3908 and K.S.A. 2024
6 Supp. 2-3901, 21-5701 and 65-4101 and repealing the existing sections.
7
8 Be it enacted by the Legislature of the State of Kansas:
9 New Section 1. (a) As used in this section:
10 (1) "Approved source" means:
11 (A) A person authorized to produce industrial hemp under a state or
12 federal plan in accordance with 7 U.S.C. § 1621 et seq., and amendments
13 thereto;
14 (B) a person registered as an industrial hemp processor by the state
15 fire marshal; or
16 (C) a person authorized by another state to process industrial hemp or
17 manufacture hemp products if such state has been approved by the Kansas
18 department of agriculture as having equivalent state standards for
19 processing, laboratory testing and labeling requirements;
20 (2) "cartoon" means any drawing or other depiction of an object,
21 person, animal, creature or any similar caricature that satisfies any of the
22 following criteria:
23 (A) The use of comically exaggerated features;
24 (B) the attribution of human characteristics to animals, plants or other
25 objects, or the similar use of anthropomorphic technique; or
26 (C) the attribution of unnatural or extra-human abilities, such as
27 imperviousness to pain or injury, X-ray vision, tunneling at very high
28 speeds or transformation;
29 (3) "child-resistant" means packaging that is:
30 (A) Designed or constructed to be significantly difficult for children
31 under five years of age to open yet not difficult for adults to use properly;
32 and
33 (B) resealable for any product intended for more than a single use or
34 containing multiple servings;
35 (4) "cosmetic" means the same as defined in K.S.A. 65-656, and
36 amendments thereto;
SB 292 2
1 (5) "department" means the Kansas department of agriculture;
2 (6) "hemp-derived cannabinoid product" means an ingestible,
3 inhalable or cosmetic product that is processed or derived from industrial
4 hemp; and
5 (7) "industrial hemp" means the same as defined in K.S.A. 2-3901,
6 and amendments thereto.
7 (b) All hemp-derived cannabinoid products sold in a retail
8 establishment shall:
9 (1) Be from an approved source;
10 (2) be packaged and labeled in accordance with this section; and
11 (3) have a valid printed certificate of analysis available upon request.
12 (c) A hemp-derived cannabinoid product, excluding cosmetics, shall
13 not be sold, gifted or otherwise transferred to any person under the age of
14 21.
15 (d) (1) Each hemp-derived cannabinoid product sold or otherwise
16 distributed in the state shall bear labeling to allow the consumer to access
17 information on the product, including a certificate of analysis for the
18 product, the location where the hemp was grown and the address and
19 phone number of the manufacturer or distributor. Such labeling shall
20 utilize the following:
21 (A) A scanning bar code, including the batch number or serial
22 number of the product;
23 (B) a quick-response code; or
24 (C) a web address linked to a document or website.
25 (2) No product labeling or advertising material for any hemp-derived
26 cannabinoid product sold or otherwise distributed in the state shall bear
27 any claims stating that the product can diagnose, treat, cure or prevent any
28 disease.
29 (3) Each container or package of hemp-derived cannabinoid product,
30 excluding cosmetics, shall:
31 (A) Have a tamper-evident seal; and
32 (B) be in child-resistant packaging.
33 (4) Each container or package of hemp-derived cannabinoid product
34 that is a cosmetic shall have a tamper-evident seal.
35 (5) Hemp-derived cannabinoid product packaging shall not include:
36 (A) Any cartoon images;
37 (B) likeness to images, characters or phrases that are popularly used
38 to advertise to children;
39 (C) likeness to or imitation of any commercially available candy,
40 snack, baked good or beverage packaging or labeling;
41 (D) the terms "candy" or "candies", or any variation in the spelling of
42 these words; or
43 (E) the logo of the department, or any seal, flag, crest, coat of arms or
SB 292 3
1 other insignia that could reasonably mislead any person to believe the
2 product has been endorsed, manufactured or used by any state, county, or
3 municipality or any agency thereof, excluding the use of seals associated
4 with state or federal programs used in accordance with state or federal law.
5 Sec. 2. K.S.A. 2024 Supp. 2-3901 is hereby amended to read as
6 follows: 2-3901. (a) K.S.A. 2-3901 et seq., and amendments thereto, shall
7 be known and may be cited as the commercial industrial hemp act.
8 (b) As used in the commercial industrial hemp act:
9 (1) "Commercial" means the cultivation or production of industrial
10 hemp for any purpose authorized under K.S.A 2-3906, and amendments
11 thereto.
12 (2) "Delta-9 tetrahydrocannabinol concentration" means the
13 combined percentage of delta-9 tetrahydrocannabinol and its optical
14 isomers, their salts and acids, and salts of their acids, reported as free
15 THC:
16 (A) On a dry weight basis, of any part of the plant cannabis sativa L.;
17 or
18 (B) on a percentage by weight basis in hemp products, waste or
19 substances resulting from the production or processing of industrial hemp.
20 (3) "Effective disposal" includes, but is not limited to:
21 (A) Destruction; or
22 (B) any other method of disposing of industrial hemp or hemp
23 products found to be in violation of this act that is permitted under the
24 provisions of 7 U.S.C. § 1621 et seq. and any rules and regulations
25 adopted thereunder.
26 (4) "Hemp products" means all products made from industrial hemp,
27 including, but not limited to, cloth, cordage, fiber, food, fuel, hemp-
28 derived cannabinoid products, paint, paper, particleboard, plastics, seed,
29 seed meal and seed oil for consumption and any extract from industrial
30 hemp intended for further processing. Final "hemp products" may contain
31 a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a
32 dry weight basis. As used in this paragraph, "tetrahydrocannabinol
33 concentration" means the same as in K.S.A. 65-6235(b)(3), and
34 amendments thereto.
35 (5) "Hemp producer" means any individual, licensed or otherwise,
36 engaging in the cultivation or production of industrial hemp for
37 commercial purposes pursuant to K.S.A. 2-3906, and amendments thereto.
38 (6) "Hemp processor" means a person registered under K.S.A. 2-
39 3907, and amendments thereto, to process and manufacture industrial
40 hemp and hemp products.
41 (7) "Industrial hemp" or "hemp" means all parts and varieties of the
42 plant cannabis sativa L., and any part of that plant, including the seeds
43 thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts,
SB 292 4
1 and salts of isomers, whether growing or not, that contain with a delta-9
2 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight
3 basis.
4 (8) "Person" means an individual, corporation, partnership,
5 association, joint stock company, trust, unincorporated organization or any
6 similar entity or any combination of the foregoing acting in concert.
7 (9) "State educational institution" means the university of Kansas,
8 Kansas state university, Wichita state university, Emporia state university,
9 Pittsburg state university, Fort Hays state university, or any other
10 accredited college, university, technical college or community college
11 within Kansas.
12 (10) "Authorized seed or clone plants" means a source of industrial
13 hemp seeds or clone plants that:
14 (A) Has been certified by a certifying agency, as defined by K.S.A. 2-
15 1415, and amendments thereto;
16 (B) has been produced from plants that were tested during the active
17 growing season and were found to produce industrial hemp having a
18 tetrahydrocannabinol concentration that does not exceed 0.3% on a dry
19 weight basis and has been certified in writing by the grower or distributor
20 of such seeds or clone plants to possess such qualities; or
21 (C) meets any other authorized standards approved by the Kansas
22 department of agriculture through rules and regulations, except that no
23 seed or clone plants shall be considered authorized seed or clone plants if
24 they do not meet any standard adopted by the United States department of
25 agriculture pursuant to 7 U.S.C. § 1621 et seq., and amendments thereto.
26 (11) "Hemp employee" means a person who has applied for
27 employment or is currently employed with the Kansas department of
28 agriculture who oversees or regulates industrial hemp.
29 (12) "Applicant" means a person who has submitted an application
30 for licensure as a hemp producer or registration as a hemp processor.
31 (13) "Hemp destruction employee" means an employee or agent of
32 the Kansas department of agriculture who participates in the effective
33 disposal of industrial hemp.
34 Sec. 3. K.S.A. 2-3908 is hereby amended to read as follows: 2-3908.
35 (a) (1) It shall be unlawful for any of the following hemp products product
36 to be manufactured, marketed, sold or distributed by any person in the
37 state of Kansas:
38 (A) Cigarettes containing industrial hemp;
39 (B) cigars containing industrial hemp;
40 (C) chew, dip or other smokeless material containing industrial hemp;
41 (D) teas containing industrial hemp;
42 (E) liquids, solids or gases containing industrial hemp for use in
43 vaporizing devices; and
SB 292 5
1 (F) any other hemp product that is intended for human or animal
2 consumption containing any ingredient derived from industrial hemp that
3 is prohibited pursuant to the Kansas food, drug and cosmetic act, K.S.A.
4 65-636 et seq., and amendments thereto, and the commercial feeding stuffs
5 act, K.S.A. 2-1001 et seq., and amendments thereto. This subparagraph
6 shall not otherwise prohibit the use of any such ingredient, including
7 cannabidiol oil, in such hemp products.
8 (2) A dietary supplement, food, beverage or cosmetic product is not
9 adulterated by the inclusion of industrial hemp as long as the industrial
10 hemp in such product meets the requirements in K.S.A. 2-3901 et seq., and
11 amendments thereto. The sale of a dietary supplement, food, beverage or
12 cosmetic that includes industrial hemp shall not be restricted or prohibited
13 based solely on the inclusion of industrial hemp, provided that the
14 industrial hemp in the product meets the requirements in K.S.A. 2-3901 et
15 seq., and amendments thereto.
16 (2)(3) As used in this subsection:
17 (A) "Human or animal consumption" means:
18 (i) Ingested orally; or
19 (ii) applied by any means such that an ingredient derived from
20 industrial hemp enters the human or animal body.
21 (B) "Intended for human or animal consumption" means:
22 (i) Designed by the manufacturer for human or animal consumption;
23 (ii) marketed for human or animal consumption; or
24 (iii) distributed with the intent that it be used for human or animal
25 consumption.
26 (b) (1) It shall be unlawful for any of the following hemp products to
27 be marketed, sold or distributed to any person in Kansas who is not
28 registered as a hemp processor pursuant to K.S.A. 2-3907, and
29 amendments thereto, or who does not possess a license by the Kansas
30 department of agriculture under any commercial plan established pursuant
31 to K.S.A. 2-3906, and amendments thereto, or the research program
32 established pursuant to K.S.A. 2-3902, and amendments thereto:
33 (A) Industrial hemp buds;
34 (B) ground industrial hemp floral material;
35 (C) ground industrial hemp leaf material; or
36 (D) any extract from industrial hemp with a delta-9
37 tetrahydrocannabinol concentration greater than 0.3% that will be further
38 processed.
39 (2) No license or registration shall be required for the transport of
40 hemp products described in paragraph (1) if such products are transported
41 between hemp producers and hemp processors or between more than one
42 hemp processor. Any such transportation of hemp products shall be subject
43 to rules and regulations promulgated by the state fire marshal pursuant to
SB 292 6
1 this act.
2 (c) (1) Upon a first conviction for a violation of this section, a person
3 shall be guilty of a class A nonperson misdemeanor.
4 (2) On a second or subsequent conviction for a violation of this
5 section, a person shall be guilty of a severity level 9, nonperson felony.
6 (d) Nothing in this section shall prohibit:
7 (1) The use of any hemp product for research purposes by a state
8 educational institution or affiliated entity; or
9 (2) the production, use or sale of any hemp product that is otherwise
10 not prohibited by state or federal law.
11 (e) This section shall be a part of and supplemental to the commercial
12 industrial hemp act, K.S.A. 2-3901 et seq., and amendments thereto.
13 Sec. 4. K.S.A. 2024 Supp. 21-5701 is hereby amended to read as
14 follows: 21-5701. As used in K.S.A. 21-5701 through 21-5717, and
15 amendments thereto:
16 (a) "Controlled substance" means any drug, substance or immediate
17 precursor included in any of the schedules designated in K.S.A. 65-4105,
18 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.
19 (b) (1) "Controlled substance analog" means a substance that is
20 intended for human consumption, and at least one of the following:
21 (A) The chemical structure of the substance is substantially similar to
22 the chemical structure of a controlled substance listed in or added to the
23 schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
24 thereto;
25 (B) the substance has a stimulant, depressant or hallucinogenic effect
26 on the central nervous system substantially similar to the stimulant,
27 depressant or hallucinogenic effect on the central nervous system of a
28 controlled substance included in the schedules designated in K.S.A. 65-
29 4105 or 65-4107, and amendments thereto; or
30 (C) with respect to a particular individual, such individual represents
31 or intends the substance to have a stimulant, depressant or hallucinogenic
32 effect on the central nervous system substantially similar to the stimulant,
33 depressant or hallucinogenic effect on the central nervous system of a
34 controlled substance included in the schedules designated in K.S.A. 65-
35 4105 or 65-4107, and amendments thereto.
36 (2) "Controlled substance analog" does not include:
37 (A) A controlled substance;
38 (B) a substance for which there is an approved new drug application;
39 or
40 (C) a substance with respect to which an exemption is in effect for
41 investigational use by a particular person under section 505 of the federal
42 food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent conduct with
43 respect to the substance is permitted by the exemption.
SB 292 7
1 (c) "Cultivate" means the planting or promotion of growth of five or
2 more plants that contain or can produce controlled substances.
3 (d) "Distribute" means the actual, constructive or attempted transfer
4 from one person to another of some item whether or not there is an agency
5 relationship. "Distribute" includes, but is not limited to, sale, offer for sale
6 or any act that causes some item to be transferred from one person to
7 another. "Distribute" does not include acts of administering, dispensing or
8 prescribing a controlled substance as authorized by the pharmacy act of the
9 state of Kansas, the uniform controlled substances act or otherwise
10 authorized by law.
11 (e) (1) "Drug" means:
12 (A) Substances recognized as drugs in the official United States
13 pharmacopeia, official homeopathic pharmacopoeia of the United States or
14 official national formulary or any supplement to any of them;
15 (B) substances intended for use in the diagnosis, cure, mitigation,
16 treatment or prevention of disease in humans or animals;
17 (C) substances, other than food, intended to affect the structure or any
18 function of the body of humans or animals; and
19 (D) substances intended for use as a component of any article
20 specified in subparagraph (A), (B) or (C).
21 (2) "Drug" does not include devices or their components, parts or
22 accessories.
23 (f) (1) "Drug paraphernalia" means all equipment and materials of
24 any kind that are used, or primarily intended or designed for use in
25 planting, propagating, cultivating, growing, harvesting, manufacturing,
26 compounding, converting, producing, processing, preparing, testing,
27 analyzing, packaging, repackaging, storing, containing, concealing,
28 injecting, ingesting, inhaling or otherwise introducing into the human body
29 a controlled substance and in violation of this act.
30 (2) "Drug paraphernalia" includes, but is not limited to:
31 (A) Kits used or intended for use in planting, propagating, cultivating,
32 growing or harvesting any species of plant that is a controlled substance or
33 from which a controlled substance can be derived;
34 (B) kits used or intended for use in manufacturing, compounding,
35 converting, producing, processing or preparing controlled substances;
36 (C) isomerization devices used or intended for use in increasing the
37 potency of any species of plant that is a controlled substance;
38 (D) testing equipment used or intended for use in identifying or in
39 analyzing the strength, effectiveness or purity of controlled substances;
40 (E) scales and balances used or intended for use in weighing or
41 measuring controlled substances;
42 (F) diluents and adulterants, including, but not limited to, quinine
43 hydrochloride, mannitol, mannite, dextrose and lactose that are used or
SB 292 8
1 intended for use in cutting controlled substances;
2 (G) separation gins and sifters used or intended for use in removing
3 twigs and seeds from or otherwise cleaning or refining marijuana;
4 (H) blenders, bowls, containers, spoons and mixing devices used or
5 intended for use in compounding controlled substances;
6 (I) capsules, balloons, envelopes, bags and other containers used or
7 intended for use in packaging small quantities of controlled substances;
8 (J) containers and other objects used or intended for use in storing or
9 concealing controlled substances;
10 (K) hypodermic syringes, needles and other objects used or intended
11 for use in parenterally injecting controlled substances into the human
12 body;
13 (L) objects used or primarily intended or designed for use in
14 ingesting, inhaling or otherwise introducing marijuana, cocaine, hashish,
15 hashish oil, phencyclidine (PCP), methamphetamine or amphetamine into
16 the human body, such as:
17 (i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with
18 or without screens, permanent screens, hashish heads or punctured metal
19 bowls;
20 (ii) water pipes, bongs or smoking pipes designed to draw smoke
21 through water or another cooling device;
22 (iii) carburetion pipes, glass or other heat-resistant tubes or any other
23 device used, intended to be used or designed to be used to cause
24 vaporization of a controlled substance for inhalation;
25 (iv) smoking and carburetion masks;
26 (v) roach clips, objects used to hold burning material, such as a
27 marijuana cigarette, that has become too small or too short to be held in
28 the hand;
29 (vi) miniature cocaine spoons and cocaine vials;
30 (vii) chamber smoking pipes;
31 (viii) carburetor smoking pipes;
32 (ix) electric smoking pipes;
33 (x) air-driven smoking pipes;
34 (xi) chillums;
35 (xii) bongs;
36 (xiii) ice pipes or chillers;
37 (xiv) any smoking pipe manufactured to disguise its intended
38 purpose;
39 (xv) wired cigarette papers; or
40 (xvi) cocaine freebase kits.
41 (3) "Drug paraphernalia" does not include:
42 (A) Any products, chemicals or materials described in K.S.A. 21-
43 5709(a), and amendments thereto; or
SB 292 9
1 (B) any materials used or intended for use to test a substance for the
2 presence of fentanyl, a fentanyl analog, ketamine or gamma
3 hydroxybutyric acid.
4 (g) "Fentanyl-related controlled substance" means any substance
5 designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b)
6 (12), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(24), (b)(26), (b)(27), (b)
7 (28), (b)(35), (b)(42), (b)(43), (b)(44), (b)(45), (b)(48), (b)(50), (b)(54), (b)
8 (55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(68), (b)(70), (b)(71), (b)(72), (b)
9 (73), (b)(74), (b)(75), (b)(76), (b)(77), (b)(78), (b)(79), (b)(80), (b)(81), (b)
10 (82), (b)(83), (b)(84), (b)(85), (b)(91), (b)(97), (b)(98), (b)(99), (b)(103),
11 (b)(104), (g)(1) or (g)(2) or 65-4107(c)(1), (c)(6), (c)(9), (c)(26), (c)(28),
12 (c)(30), (f)(3)(A) or (f)(3)(B), and amendments thereto, or any analog
13 thereof.
14 (h) "Immediate precursor" means a substance that the state board of
15 pharmacy has found to be and by rules and regulations designates as being
16 the principal compound commonly used or produced primarily for use and
17 that is an immediate chemical intermediary used or likely to be used in the
18 manufacture of a controlled substance, the control of which is necessary to
19 prevent, curtail or limit manufacture.
20 (i) "Isomer" means all enantiomers and diastereomers.
21 (j) "Manufacture" means the production, preparation, propagation,
22 compounding, conversion or processing of or placing into pill or capsule
23 form a controlled substance either directly or indirectly or by extraction
24 from substances of natural origin or independently by means of chemical
25 synthesis or by a combination of extraction and chemical synthesis.
26 "Manufacture" does not include:
27 (1) The preparation or compounding of a controlled substance by an
28 individual for the individual's own lawful use or the preparation,
29 compounding, packaging or labeling of a controlled substance:
30 (A) By a practitioner or the practitioner's agent pursuant to a lawful
31 order of a practitioner as an incident to the practitioner's administering or
32 dispensing of a controlled substance in the course of the practitioner's
33 professional practice; or
34 (B) by a practitioner or by the practitioner's authorized agent under
35 such practitioner's supervision for the purpose of or as an incident to
36 research, teaching or chemical analysis or by a pharmacist or medical care
37 facility as an incident to dispensing of a controlled substance; or
38 (2) the addition of diluents or adulterants, including, but not limited
39 to, quinine hydrochloride, mannitol, mannite, dextrose or lactose that are
40 intended for use in cutting a controlled substance.
41 (k) "Marijuana" means all parts of all varieties of the plant Cannabis
42 whether growing or not, the seeds thereof, the resin extracted from any
43 part of the plant and every compound, manufacture, salt, derivative,
SB 292 10
1 mixture or preparation of the plant, its seeds or resin. "Marijuana" does not
2 include:
3 (1) The mature stalks of the plant, fiber produced from the stalks, oil
4 or cake made from the seeds of the plant, any other compound,
5 manufacture, salt, derivative, mixture or preparation of the mature stalks,
6 except the resin extracted therefrom, fiber, oil or cake or the sterilized seed
7 of the plant that is incapable of germination;
8 (2) any substance listed in schedules II through V of the uniform
9 controlled substances act;
10 (3) drug products approved by the United States food and drug
11 administration as of the effective date of this act;
12 (4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-
13 2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
14 (5) industrial hemp as defined in K.S.A. 2-3901, and amendments
15 thereto, when cultivated, produced, possessed or used for activities
16 authorized by the commercial industrial hemp act.
17 (l) "Minor" means a person under 18 years of age.
18 (m) "Narcotic drug" means any of the following whether produced
19 directly or indirectly by extraction from substances of vegetable origin or
20 independently by means of chemical synthesis or by a combination of
21 extraction and chemical synthesis:
22 (1) Opium and opiate and any salt, compound, derivative or
23 preparation of opium or opiate;
24 (2) any salt, compound, isomer, derivative or preparation thereof that
25 is chemically equivalent or identical with any of the substances referred to
26 in paragraph (1) but not including the isoquinoline alkaloids of opium;
27 (3) opium poppy and poppy straw;
28 (4) coca leaves and any salt, compound, derivative or preparation of
29 coca leaves and any salt, compound, isomer, derivative or preparation
30 thereof that is chemically equivalent or identical with any of these
31 substances, but not including decocainized coca leaves or extractions of
32 coca leaves that do not contain cocaine or ecgonine.
33 (n) "Opiate" means any substance having an addiction-forming or
34 addiction-sustaining liability similar to morphine or being capable of
35 conversion into a drug having addiction-forming or addiction-sustaining
36 liability. "Opiate" does not include, unless specifically designated as
37 controlled under K.S.A. 65-4102, and amendments thereto, the
38 dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts
39 (dextromethorphan). "Opiate" does include its racemic and levorotatory
40 forms.
41 (o) "Opium poppy" means the plant of the species Papaver
42 somniferum l. except its seeds.
43 (p) "Person" means an individual, corporation, government or
SB 292 11
1 governmental subdivision or agency, business trust, estate, trust,
2 partnership, association or any other legal entity.
3 (q) "Poppy straw" means all parts, except the seeds, of the opium
4 poppy, after mowing.
5 (r) "School property" means property upon which is located a
6 structure used by a unified school district or an accredited nonpublic
7 school for student instruction or attendance or extracurricular activities of
8 pupils enrolled in kindergarten or any of the grades one through 12. This
9 definition shall not be construed as requiring that school be in session or
10 that classes are actually being held at the time of the offense or that
11 children must be present within the structure or on the property during the
12 time of any alleged criminal act. If the structure or property meets the
13 above definition, the actual use of that structure or property at the time
14 alleged shall not be a defense to the crime charged or the sentence
15 imposed.
16 (s) "Simulated controlled substance" means any product that
17 identifies itself by a common name or slang term associated with a
18 controlled substance and that indicates on its label or accompanying
19 promotional material that the product simulates the effect of a controlled
20 substance.
21 Sec. 5. K.S.A. 2024 Supp. 65-4101 is hereby amended to read as
22 follows: 65-4101. As used in this act:
23 (a) "Administer" means the direct application of a controlled
24 substance, whether by injection, inhalation, ingestion or any other means,
25 to the body of a patient or research subject by:
26 (1) A practitioner or pursuant to the lawful direction of a practitioner;
27 or
28 (2) the patient or research subject at the direction and in the presence
29 of the practitioner.
30 (b) "Agent" means an authorized person who acts on behalf of or at
31 the direction of a manufacturer, distributor or dispenser. "Agent" does not
32 include a common carrier, public warehouseman or employee of the carrier
33 or warehouseman.
34 (c) "Application service provider" means an entity that sells
35 electronic prescription or pharmacy prescription applications as a hosted
36 service where the entity controls access to the application and maintains
37 the software and records on its server.
38 (d) "Board" means the state board of pharmacy.
39 (e) "Bureau" means the bureau of narcotics and dangerous drugs,
40 United States department of justice, or its successor agency.
41 (f) "Controlled substance" means any drug, substance or immediate
42 precursor included in any of the schedules designated in K.S.A. 65-4105,
43 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.
SB 292 12
1 (g) (1) "Controlled substance analog" means a substance that is
2 intended for human consumption, and at least one of the following:
3 (A) The chemical structure of the substance is substantially similar to
4 the chemical structure of a controlled substance listed in or added to the
5 schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
6 thereto;
7 (B) the substance has a stimulant, depressant or hallucinogenic effect
8 on the central nervous system substantially similar to the stimulant,
9 depressant or hallucinogenic effect on the central nervous system of a
10 controlled substance included in the schedules designated in K.S.A. 65-
11 4105 or 65-4107, and amendments thereto; or
12 (C) with respect to a particular individual, such individual represents
13 or intends the substance to have a stimulant, depressant or hallucinogenic
14 effect on the central nervous system substantially similar to the stimulant,
15 depressant or hallucinogenic effect on the central nervous system of a
16 controlled substance included in the schedules designated in K.S.A. 65-
17 4105 or 65-4107, and amendments thereto.
18 (2) "Controlled substance analog" does not include:
19 (A) A controlled substance;
20 (B) a substance for which there is an approved new drug application;
21 or
22 (C) a substance with respect to which an exemption is in effect for
23 investigational use by a particular person under section 505 of the federal
24 food, drug and cosmetic act, 21 U.S.C. § 355, to the extent conduct with
25 respect to the substance is permitted by the exemption.
26 (h) "Counterfeit substance" means a controlled substance that, or the
27 container or labeling of which, without authorization bears the trademark,
28 trade name or other identifying mark, imprint, number or device or any
29 likeness thereof of a manufacturer, distributor or dispenser other than the
30 person who in fact manufactured, distributed or dispensed the substance.
31 (i) "Cultivate" means the planting or promotion of growth of five or
32 more plants that contain or can produce controlled substances.
33 (j) "DEA" means the U.S. department of justice, drug enforcement
34 administration.
35 (k) "Deliver" or "delivery" means the actual, constructive or
36 attempted transfer from one person to another of a controlled substance,
37 whether or not there is an agency relationship.
38 (l) "Dispense" means to deliver a controlled substance to an ultimate
39 user or research subject by or pursuant to the lawful order of a practitioner,
40 including the packaging, labeling or compounding necessary to prepare the
41 substance for that delivery, or pursuant to the prescription of a mid-level
42 practitioner.
43 (m) "Dispenser" means a practitioner or pharmacist who dispenses, or
SB 292 13
1 a physician assistant who has authority to dispense prescription-only drugs
2 in accordance with K.S.A. 65-28a08(b), and amendments thereto.
3 (n) "Distribute" means to deliver other than by administering or
4 dispensing a controlled substance.
5 (o) "Distributor" means a person who distributes.
6 (p) (1) "Drug" means substances:
7 (A) Recognized as drugs in the official United States pharmacopeia,
8 official homeopathic pharmacopoeia of the United States or official
9 national formulary or any supplement to any of them;
10 (B) intended for use in the diagnosis, cure, mitigation, treatment or
11 prevention of disease in human or animals;
12 (C) other than food intended to affect the structure or any function of
13 the body of human or animals; and
14 (D) intended for use as a component of any article specified in
15 subparagraph (A), (B) or (C).
16 (2) "Drug" does not include devices or their components, parts or
17 accessories.
18 (q) "Immediate precursor" means a substance that the board has
19 found to be and by rule and regulation designates as being the principal
20 compound commonly used or produced primarily for use and that is an
21 immediate chemical intermediary used or likely to be used in the
22 manufacture of a controlled substance, the control of which is necessary to
23 prevent, curtail or limit manufacture.
24 (r) "Electronic prescription" means an electronically prepared
25 prescription that is authorized and transmitted from the prescriber to the
26 pharmacy by means of electronic transmission.
27 (s) "Electronic prescription application" means software that is used
28 to create electronic prescriptions and that is intended to be installed on the
29 prescriber's computers and servers where access and records are controlled
30 by the prescriber.
31 (t) "Electronic signature" means a confidential personalized digital
32 key, code, number or other method for secure electronic data transmissions
33 that identifies a particular person as the source of the message,
34 authenticates the signatory of the message and indicates the person's
35 approval of the information contained in the transmission.
36 (u) "Electronic transmission" means the transmission of an electronic
37 prescription, formatted as an electronic data file, from a prescriber's
38 electronic prescription application to a pharmacy's computer, where the
39 data file is imported into the pharmacy prescription application.
40 (v) "Electronically prepared prescription" means a prescription that is
41 generated using an electronic prescription application.
42 (w) "Facsimile transmission" or "fax transmission" means the
43 transmission of a digital image of a prescription from the prescriber or the
SB 292 14
1 prescriber's agent to the pharmacy. "Facsimile transmission" includes, but
2 is not limited to, transmission of a written prescription between the
3 prescriber's fax machine and the pharmacy's fax machine; transmission of
4 an electronically prepared prescription from the prescriber's electronic
5 prescription application to the pharmacy's fax machine, computer or
6 printer; or transmission of an electronically prepared prescription from the
7 prescriber's fax machine to the pharmacy's fax machine, computer or
8 printer.
9 (x) "Intermediary" means any technology system that receives and
10 transmits an electronic prescription between the prescriber and the
11 pharmacy.
12 (y) "Isomer" means all enantiomers and diastereomers.
13 (z) "Manufacture" means the production, preparation, propagation,
14 compounding, conversion or processing of a controlled substance either
15 directly or indirectly or by extraction from substances of natural origin or
16 independently by means of chemical synthesis or by a combination of
17 extraction and chemical synthesis and includes any packaging or
18 repackaging of the substance or labeling or relabeling of its container,
19 except that this term does not include the preparation or compounding of a
20 controlled substance by an individual for the individual's own lawful use
21 or the preparation, compounding, packaging or labeling of a controlled
22 substance:
23 (1) By a practitioner or the practitioner's agent pursuant to a lawful
24 order of a practitioner as an incident to the practitioner's administering or
25 dispensing of a controlled substance in the course of the practitioner's
26 professional practice; or
27 (2) by a practitioner or by the practitioner's authorized agent under
28 such practitioner's supervision for the purpose of or as an incident to
29 research, teaching or chemical analysis or by a pharmacist or medical care
30 facility as an incident to dispensing of a controlled substance.
31 (aa) "Marijuana" means all parts of all varieties of the plant Cannabis
32 whether growing or not, the seeds thereof, the resin extracted from any
33 part of the plant and every compound, manufacture, salt, derivative,
34 mixture or preparation of the plant, its seeds or resin. It does not include:
35 (1) The mature stalks of the plant, fiber produced from the stalks, oil
36 or cake made from the seeds of the plant, any other compound,
37 manufacture, salt, derivative, mixture or preparation of the mature stalks,
38 except the resin extracted therefrom, fiber, oil or cake or the sterilized seed
39 of the plant that is incapable of germination;
40 (2) any substance listed in schedules II through V of the uniform
41 controlled substances act;
42 (3) drug products approved by the United States food and drug
43 administration as of the effective date of this act;
SB 292 15
1 (4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-
2 2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
3 (5) industrial hemp as defined in K.S.A. 2-3901, and amendments
4 thereto, when cultivated, produced, possessed or used for activities
5 authorized by the commercial industrial hemp act.
6 (bb) "Medical care facility" shall have the meaning ascribed to that
7 term in K.S.A. 65-425, and amendments thereto.
8 (cc) "Mid-level practitioner" means a certified nurse-midwife
9 engaging in the independent practice of midwifery under the independent
10 practice of midwifery act, an advanced practice registered nurse issued a
11 license pursuant to K.S.A. 65-1131, and amendments thereto, who has
12 authority to prescribe drugs under K.S.A. 65-1130, and amendments
13 thereto, or a physician assistant licensed under the physician assistant
14 licensure act who has authority to prescribe drugs pursuant to a written
15 agreement with a supervising physician under K.S.A. 65-28a08, and
16 amendments thereto.
17 (dd) "Narcotic drug" means any of the following whether produced
18 directly or indirectly by extraction from substances of vegetable origin or
19 independently by means of chemical synthesis or by a combination of
20 extraction and chemical synthesis:
21 (1) Opium and opiate and any salt, compound, derivative or
22 preparation of opium or opiate;
23 (2) any salt, compound, isomer, derivative or preparation thereof that
24 is chemically equivalent or identical with any of the substances referred to
25 in paragraph (1) but not including the isoquinoline alkaloids of opium;
26 (3) opium poppy and poppy straw;
27 (4) coca leaves and any salt, compound, derivative or preparation of
28 coca leaves, and any salt, compound, isomer, derivative or preparation
29 thereof that is chemically equivalent or identical with any of these
30 substances, but not including decocainized coca leaves or extractions of
31 coca leaves that do not contain cocaine or ecgonine.
32 (ee) "Opiate" means any substance having an addiction-forming or
33 addiction-sustaining liability similar to morphine or being capable of
34 conversion into a drug having addiction-forming or addiction-sustaining
35 liability. It does not include, unless specifically designated as controlled
36 under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer
37 of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). It does
38 include its racemic and levorotatory forms.
39 (ff) "Opium poppy" means the plant of the species Papaver
40 somniferum l. except its seeds.
41 (gg) "Person" means an individual, corporation, government, or
42 governmental subdivision or agency, business trust, estate, trust,
43 partnership or association or any other legal entity.
SB 292 16
1 (hh) "Pharmacist" means any natural person licensed under K.S.A.
2 65-1625 et seq., and amendments thereto, to practice pharmacy.
3 (ii) "Pharmacist intern" means: (1) A student currently enrolled in an
4 accredited pharmacy program; (2) a graduate of an accredited pharmacy
5 program serving such person's internship; or (3) a graduate of a pharmacy
6 program located outside of the United States that is not accredited and who
7 had successfully passed equivalency examinations approved by the board.
8 (jj) "Pharmacy prescription application" means software that is used
9 to process prescription information, is installed on a pharmacy's computers
10 and servers, and is controlled by the pharmacy.
11 (kk) "Poppy straw" means all parts, except the seeds, of the opium
12 poppy, after mowing.
13 (ll) "Practitioner" means a person licensed to practice medicine and
14 surgery, dentist, podiatrist, veterinarian, optometrist, or scientific
15 investigator or other person authorized by law to use a controlled
16 substance in teaching or chemical analysis or to conduct research with
17 respect to a controlled substance.
18 (mm) "Prescriber" means a practitioner or a mid-level practitioner.
19 (nn) "Production" includes the manufacture, planting, cultivation,
20 growing or harvesting of a controlled substance.
21 (oo) "Readily retrievable" means that records kept by automatic data
22 processing applications or other electronic or mechanized recordkeeping
23 systems can be separated out from all other records within a reasonable
24 time not to exceed 48 hours of a request from the board or other authorized
25 agent or that hard-copy records are kept on which certain items are
26 asterisked, redlined or in some other manner visually identifiable apart
27 from other items appearing on the records.
28 (pp) "Ultimate user" means a person who lawfully possesses a
29 controlled substance for such person's own use or for the use of a member
30 of such person's household or for administering to an animal owned by
31 such person or by a member of such person's household.
32 Sec. 6. K.S.A. 2-3908 and K.S.A. 2024 Supp. 2-3901, 21-5701 and
33 65-4101 are hereby repealed.
34 Sec. 7. This act shall take effect and be in force from and after its
35 publication in the statute book.
[DELETED: AN AT cg il h; rg to hcprhSBN0(1(2f3t4(5f6(7m8dt of ae as hg et se ss f9p0(1p2f3(4(5o6(7i8s9(0(1u2a3(4c5(6a]
[DELETED: 2((d cd p" ms an iih(a(l hd cd ps sd in a re(0(1(2(3n425(6d7i8p9p0u1(2n3(4(5(6c7a8d9(0e1(2(3(4t5(6(7(8t9(0s1(2t3(]
[DELETED: 2opmwSfb((0h1t2(9 tl c" ms t3cd e o d tl  is o4i5T6(7o8(9s0(1(2(3p4p. 5a6(7i h8d9s0h1a2dy wt b As ud in ts p, "3c" ms te se as in K. 6, a4a5(6eg in te cn or pn of il hp f7c8(930h1(2p3t]
[DELETED: 2atb(" ms an i, c, pas(KPg se u, Ft Hs se u, or ay o0a1w2(3h4(516(7g8t9w0o1(2d3s4t5a6(p e" ms a pn wo hs ad f7e8a9(0f1(2t3d4S5(6t7s8(9(0(1(2(3v]
[DELETED: 2( t ici6asc(a0h1a2c3b4i5s6(7(8(9(0i1(2(3(4(5c6(7b8rd as a hp pr pt to K. 2, a9a0d1t2e3(4(5(6(y et fm il hp wh a d7t8p9(0h1b2h3t]
[DELETED: 2t(s(s((e(0n1(2i3S4f. 5a6(7p869(0i1(2t3s4t5(6o7d8c940(1o2e3d4c546(7(8(9o0(1i2f3r]
[DELETED: 2(m(froaps0a1(2(3p4o5(6t7(8f9(0s1(2a3(4a5p6c, c, p, p, p, t7a, p, r, s, c, c8i9a0(1(2g3f4(5c6(7p8(9a0(1m2(3h]
[DELETED: 2i(t(i(i(c0(1f2b3(s ud or p id or dd fr ue i4i5h6t7(8o9b0(1t2(3d4v5(6(7m8t9(0(1(2(3(4(5(6(7(y sg pe md to de is i8p9(0(1(2(35]
[DELETED: 2(pe of f, a fl a, ke or gh(d cd s" ms a sd((((0(1(2(3t4(5p6t7t8m9p0(1(2c3f4f5s6"7(8il fr te is on ll ue or te p9c0(1o2d3p4(5s6r7f8(9t0i1(2w3p]
[DELETED: 21mi(or ce me fm te ss of te p, ay or cmeo(c0(1a2(324(5t wn c, p, pd or ud fr a6a7(8(9d0i1e2(m ad oe ad ay s, c, de o3p4(5i6i7(8(9c0t1s2c3(4a5c6l7cd ur K. 6, ad as t, t8d ir of 3n ad is s9(0f1(m p" ms te pt of te ss P2s3(" ms an i, c, gt o]
[DELETED: 21gl sn or a, bs t, e, tp(p(l p" ms p un wh is ld asspd0t1c2t3a4a5i6(d cd s" ms ay pt t7i8c9p0s1S2f3(" ms te dt an of a c4s5t6(7o8(9o0(1t2i3o4(n se p" ms an ey tt s5e6s7t8(9(0U1(2p36]
[DELETED: 21(i(tst(od0c142(3o4e5d6c748(9(0(1o2(3i4f5r6(7c8t9l0p1(2m3(4a5(" or "" ms te a, ce o6a7w8(9u0i1s2p3(]
[DELETED: 21ai(d(((on0(1p2(3t4(5s6(7a8(9f0c1ie cl i u or l to be u in t2m3p4(c p" ms an ey p5p6p7(8t9p0b1(2k3tt is a pr pn as te se of te m4a5a6(7p8e9d0(1g2(e t" or "x t" ms t3t]
[DELETED: 21pipapppp(0ts an ec pn bn te pr ad t1p2(3(4c5d6i7en ad cl ss ad is ay pg o8r9e0c1o2s3(4o5d6p7(8s9r0f1(2w3p4m5(6or ce me fm te ss of te p, ay or c7m8e9o0(1c2(3a]
[DELETED: 21(2(t wn c, p, pd or ud fr aa(t(l p" ms a cd ne0p1l2a3t4l5a6a7(8d9i0e1(m ad oe ad ay s, c, de o2p3(4i5i6(7(8c9t0s1c2(3a4c5l6u7o8i9(m p" ms te pt of te ss P0s1(" ms an i, c, g, o2gl sn or a, bs t, e, t3p]
[DELETED: 21(6(apph(t0a1(2p3(4s, d, p, v, o, or s5i o o p a l t a c6s7r8(9(0g1(2p3s4t5a6a7f8(s s 9c0o1s2S364S5p]


================================================================================

Raw Text:
Session of 2025
SENATE BILL No. 292
By Committee on Federal and State Affairs
3-6
1 AN ACT concerning industrial hemp; relating to hemp-derived
2 cannabinoid products; prohibiting the transfer of such products to any
3 person under the age of 21; establishing packaging and labeling
4 requirements for such products; amending the definition of industrial
5 hemp and hemp products; amending K.S.A. 2-3908 and K.S.A. 2024
6 Supp. 2-3901, 21-5701 and 65-4101 and repealing the existing sections.
7
8 Be it enacted by the Legislature of the State of Kansas:
9 New Section 1. (a) As used in this section:
10 (1) "Approved source" means:
11 (A) A person authorized to produce industrial hemp under a state or
12 federal plan in accordance with 7 U.S.C. § 1621 et seq., and amendments
13 thereto;
14 (B) a person registered as an industrial hemp processor by the state
15 fire marshal; or
16 (C) a person authorized by another state to process industrial hemp or
17 manufacture hemp products if such state has been approved by the Kansas
18 department of agriculture as having equivalent state standards for
19 processing, laboratory testing and labeling requirements;
20 (2) "cartoon" means any drawing or other depiction of an object,
21 person, animal, creature or any similar caricature that satisfies any of the
22 following criteria:
23 (A) The use of comically exaggerated features;
24 (B) the attribution of human characteristics to animals, plants or other
25 objects, or the similar use of anthropomorphic technique; or
26 (C) the attribution of unnatural or extra-human abilities, such as
27 imperviousness to pain or injury, X-ray vision, tunneling at very high
28 speeds or transformation;
29 (3) "child-resistant" means packaging that is:
30 (A) Designed or constructed to be significantly difficult for children
31 under five years of age to open yet not difficult for adults to use properly;
32 and
33 (B) resealable for any product intended for more than a single use or
34 containing multiple servings;
35 (4) "cosmetic" means the same as defined in K.S.A. 65-656, and
36 amendments thereto;

SB 292 2
1 (5) "department" means the Kansas department of agriculture;
2 (6) "hemp-derived cannabinoid product" means an ingestible,
3 inhalable or cosmetic product that is processed or derived from industrial
4 hemp; and
5 (7) "industrial hemp" means the same as defined in K.S.A. 2-3901,
6 and amendments thereto.
7 (b) All hemp-derived cannabinoid products sold in a retail
8 establishment shall:
9 (1) Be from an approved source;
10 (2) be packaged and labeled in accordance with this section; and
11 (3) have a valid printed certificate of analysis available upon request.
12 (c) A hemp-derived cannabinoid product, excluding cosmetics, shall
13 not be sold, gifted or otherwise transferred to any person under the age of
14 21.
15 (d) (1) Each hemp-derived cannabinoid product sold or otherwise
16 distributed in the state shall bear labeling to allow the consumer to access
17 information on the product, including a certificate of analysis for the
18 product, the location where the hemp was grown and the address and
19 phone number of the manufacturer or distributor. Such labeling shall
20 utilize the following:
21 (A) A scanning bar code, including the batch number or serial
22 number of the product;
23 (B) a quick-response code; or
24 (C) a web address linked to a document or website.
25 (2) No product labeling or advertising material for any hemp-derived
26 cannabinoid product sold or otherwise distributed in the state shall bear
27 any claims stating that the product can diagnose, treat, cure or prevent any
28 disease.
29 (3) Each container or package of hemp-derived cannabinoid product,
30 excluding cosmetics, shall:
31 (A) Have a tamper-evident seal; and
32 (B) be in child-resistant packaging.
33 (4) Each container or package of hemp-derived cannabinoid product
34 that is a cosmetic shall have a tamper-evident seal.
35 (5) Hemp-derived cannabinoid product packaging shall not include:
36 (A) Any cartoon images;
37 (B) likeness to images, characters or phrases that are popularly used
38 to advertise to children;
39 (C) likeness to or imitation of any commercially available candy,
40 snack, baked good or beverage packaging or labeling;
41 (D) the terms "candy" or "candies", or any variation in the spelling of
42 these words; or
43 (E) the logo of the department, or any seal, flag, crest, coat of arms or

SB 292 3
1 other insignia that could reasonably mislead any person to believe the
2 product has been endorsed, manufactured or used by any state, county, or
3 municipality or any agency thereof, excluding the use of seals associated
4 with state or federal programs used in accordance with state or federal law.
5 Sec. 2. K.S.A. 2024 Supp. 2-3901 is hereby amended to read as
6 follows: 2-3901. (a) K.S.A. 2-3901 et seq., and amendments thereto, shall
7 be known and may be cited as the commercial industrial hemp act.
8 (b) As used in the commercial industrial hemp act:
9 (1) "Commercial" means the cultivation or production of industrial
10 hemp for any purpose authorized under K.S.A 2-3906, and amendments
11 thereto.
12 (2) "Delta-9 tetrahydrocannabinol concentration" means the
13 combined percentage of delta-9 tetrahydrocannabinol and its optical
14 isomers, their salts and acids, and salts of their acids, reported as free
15 THC:
16 (A) On a dry weight basis, of any part of the plant cannabis sativa L.;
17 or
18 (B) on a percentage by weight basis in hemp products, waste or
19 substances resulting from the production or processing of industrial hemp.
20 (3) "Effective disposal" includes, but is not limited to:
21 (A) Destruction; or
22 (B) any other method of disposing of industrial hemp or hemp
23 products found to be in violation of this act that is permitted under the
24 provisions of 7 U.S.C. § 1621 et seq. and any rules and regulations
25 adopted thereunder.
26 (4) "Hemp products" means all products made from industrial hemp,
27 including, but not limited to, cloth, cordage, fiber, food, fuel, hemp-
28 derived cannabinoid products, paint, paper, particleboard, plastics, seed,
29 seed meal and seed oil for consumption and any extract from industrial
30 hemp intended for further processing. Final "hemp products" may contain
31 a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a
32 dry weight basis. As used in this paragraph, "tetrahydrocannabinol
33 concentration" means the same as in K.S.A. 65-6235(b)(3), and
34 amendments thereto.
35 (5) "Hemp producer" means any individual, licensed or otherwise,
36 engaging in the cultivation or production of industrial hemp for
37 commercial purposes pursuant to K.S.A. 2-3906, and amendments thereto.
38 (6) "Hemp processor" means a person registered under K.S.A. 2-
39 3907, and amendments thereto, to process and manufacture industrial
40 hemp and hemp products.
41 (7) "Industrial hemp" or "hemp" means all parts and varieties of the
42 plant cannabis sativa L., and any part of that plant, including the seeds
43 thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts,

SB 292 4
1 and salts of isomers, whether growing or not, that contain with a delta-9
2 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight
3 basis.
4 (8) "Person" means an individual, corporation, partnership,
5 association, joint stock company, trust, unincorporated organization or any
6 similar entity or any combination of the foregoing acting in concert.
7 (9) "State educational institution" means the university of Kansas,
8 Kansas state university, Wichita state university, Emporia state university,
9 Pittsburg state university, Fort Hays state university, or any other
10 accredited college, university, technical college or community college
11 within Kansas.
12 (10) "Authorized seed or clone plants" means a source of industrial
13 hemp seeds or clone plants that:
14 (A) Has been certified by a certifying agency, as defined by K.S.A. 2-
15 1415, and amendments thereto;
16 (B) has been produced from plants that were tested during the active
17 growing season and were found to produce industrial hemp having a
18 tetrahydrocannabinol concentration that does not exceed 0.3% on a dry
19 weight basis and has been certified in writing by the grower or distributor
20 of such seeds or clone plants to possess such qualities; or
21 (C) meets any other authorized standards approved by the Kansas
22 department of agriculture through rules and regulations, except that no
23 seed or clone plants shall be considered authorized seed or clone plants if
24 they do not meet any standard adopted by the United States department of
25 agriculture pursuant to 7 U.S.C. § 1621 et seq., and amendments thereto.
26 (11) "Hemp employee" means a person who has applied for
27 employment or is currently employed with the Kansas department of
28 agriculture who oversees or regulates industrial hemp.
29 (12) "Applicant" means a person who has submitted an application
30 for licensure as a hemp producer or registration as a hemp processor.
31 (13) "Hemp destruction employee" means an employee or agent of
32 the Kansas department of agriculture who participates in the effective
33 disposal of industrial hemp.
34 Sec. 3. K.S.A. 2-3908 is hereby amended to read as follows: 2-3908.
35 (a) (1) It shall be unlawful for any of the following hemp products product
36 to be manufactured, marketed, sold or distributed by any person in the
37 state of Kansas:
38 (A) Cigarettes containing industrial hemp;
39 (B) cigars containing industrial hemp;
40 (C) chew, dip or other smokeless material containing industrial hemp;
41 (D) teas containing industrial hemp;
42 (E) liquids, solids or gases containing industrial hemp for use in
43 vaporizing devices; and

SB 292 5
1 (F) any other hemp product that is intended for human or animal
2 consumption containing any ingredient derived from industrial hemp that
3 is prohibited pursuant to the Kansas food, drug and cosmetic act, K.S.A.
4 65-636 et seq., and amendments thereto, and the commercial feeding stuffs
5 act, K.S.A. 2-1001 et seq., and amendments thereto. This subparagraph
6 shall not otherwise prohibit the use of any such ingredient, including
7 cannabidiol oil, in such hemp products.
8 (2) A dietary supplement, food, beverage or cosmetic product is not
9 adulterated by the inclusion of industrial hemp as long as the industrial
10 hemp in such product meets the requirements in K.S.A. 2-3901 et seq., and
11 amendments thereto. The sale of a dietary supplement, food, beverage or
12 cosmetic that includes industrial hemp shall not be restricted or prohibited
13 based solely on the inclusion of industrial hemp, provided that the
14 industrial hemp in the product meets the requirements in K.S.A. 2-3901 et
15 seq., and amendments thereto.
16 (2)(3) As used in this subsection:
17 (A) "Human or animal consumption" means:
18 (i) Ingested orally; or
19 (ii) applied by any means such that an ingredient derived from
20 industrial hemp enters the human or animal body.
21 (B) "Intended for human or animal consumption" means:
22 (i) Designed by the manufacturer for human or animal consumption;
23 (ii) marketed for human or animal consumption; or
24 (iii) distributed with the intent that it be used for human or animal
25 consumption.
26 (b) (1) It shall be unlawful for any of the following hemp products to
27 be marketed, sold or distributed to any person in Kansas who is not
28 registered as a hemp processor pursuant to K.S.A. 2-3907, and
29 amendments thereto, or who does not possess a license by the Kansas
30 department of agriculture under any commercial plan established pursuant
31 to K.S.A. 2-3906, and amendments thereto, or the research program
32 established pursuant to K.S.A. 2-3902, and amendments thereto:
33 (A) Industrial hemp buds;
34 (B) ground industrial hemp floral material;
35 (C) ground industrial hemp leaf material; or
36 (D) any extract from industrial hemp with a delta-9
37 tetrahydrocannabinol concentration greater than 0.3% that will be further
38 processed.
39 (2) No license or registration shall be required for the transport of
40 hemp products described in paragraph (1) if such products are transported
41 between hemp producers and hemp processors or between more than one
42 hemp processor. Any such transportation of hemp products shall be subject
43 to rules and regulations promulgated by the state fire marshal pursuant to

SB 292 6
1 this act.
2 (c) (1) Upon a first conviction for a violation of this section, a person
3 shall be guilty of a class A nonperson misdemeanor.
4 (2) On a second or subsequent conviction for a violation of this
5 section, a person shall be guilty of a severity level 9, nonperson felony.
6 (d) Nothing in this section shall prohibit:
7 (1) The use of any hemp product for research purposes by a state
8 educational institution or affiliated entity; or
9 (2) the production, use or sale of any hemp product that is otherwise
10 not prohibited by state or federal law.
11 (e) This section shall be a part of and supplemental to the commercial
12 industrial hemp act, K.S.A. 2-3901 et seq., and amendments thereto.
13 Sec. 4. K.S.A. 2024 Supp. 21-5701 is hereby amended to read as
14 follows: 21-5701. As used in K.S.A. 21-5701 through 21-5717, and
15 amendments thereto:
16 (a) "Controlled substance" means any drug, substance or immediate
17 precursor included in any of the schedules designated in K.S.A. 65-4105,
18 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.
19 (b) (1) "Controlled substance analog" means a substance that is
20 intended for human consumption, and at least one of the following:
21 (A) The chemical structure of the substance is substantially similar to
22 the chemical structure of a controlled substance listed in or added to the
23 schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
24 thereto;
25 (B) the substance has a stimulant, depressant or hallucinogenic effect
26 on the central nervous system substantially similar to the stimulant,
27 depressant or hallucinogenic effect on the central nervous system of a
28 controlled substance included in the schedules designated in K.S.A. 65-
29 4105 or 65-4107, and amendments thereto; or
30 (C) with respect to a particular individual, such individual represents
31 or intends the substance to have a stimulant, depressant or hallucinogenic
32 effect on the central nervous system substantially similar to the stimulant,
33 depressant or hallucinogenic effect on the central nervous system of a
34 controlled substance included in the schedules designated in K.S.A. 65-
35 4105 or 65-4107, and amendments thereto.
36 (2) "Controlled substance analog" does not include:
37 (A) A controlled substance;
38 (B) a substance for which there is an approved new drug application;
39 or
40 (C) a substance with respect to which an exemption is in effect for
41 investigational use by a particular person under section 505 of the federal
42 food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent conduct with
43 respect to the substance is permitted by the exemption.

SB 292 7
1 (c) "Cultivate" means the planting or promotion of growth of five or
2 more plants that contain or can produce controlled substances.
3 (d) "Distribute" means the actual, constructive or attempted transfer
4 from one person to another of some item whether or not there is an agency
5 relationship. "Distribute" includes, but is not limited to, sale, offer for sale
6 or any act that causes some item to be transferred from one person to
7 another. "Distribute" does not include acts of administering, dispensing or
8 prescribing a controlled substance as authorized by the pharmacy act of the
9 state of Kansas, the uniform controlled substances act or otherwise
10 authorized by law.
11 (e) (1) "Drug" means:
12 (A) Substances recognized as drugs in the official United States
13 pharmacopeia, official homeopathic pharmacopoeia of the United States or
14 official national formulary or any supplement to any of them;
15 (B) substances intended for use in the diagnosis, cure, mitigation,
16 treatment or prevention of disease in humans or animals;
17 (C) substances, other than food, intended to affect the structure or any
18 function of the body of humans or animals; and
19 (D) substances intended for use as a component of any article
20 specified in subparagraph (A), (B) or (C).
21 (2) "Drug" does not include devices or their components, parts or
22 accessories.
23 (f) (1) "Drug paraphernalia" means all equipment and materials of
24 any kind that are used, or primarily intended or designed for use in
25 planting, propagating, cultivating, growing, harvesting, manufacturing,
26 compounding, converting, producing, processing, preparing, testing,
27 analyzing, packaging, repackaging, storing, containing, concealing,
28 injecting, ingesting, inhaling or otherwise introducing into the human body
29 a controlled substance and in violation of this act.
30 (2) "Drug paraphernalia" includes, but is not limited to:
31 (A) Kits used or intended for use in planting, propagating, cultivating,
32 growing or harvesting any species of plant that is a controlled substance or
33 from which a controlled substance can be derived;
34 (B) kits used or intended for use in manufacturing, compounding,
35 converting, producing, processing or preparing controlled substances;
36 (C) isomerization devices used or intended for use in increasing the
37 potency of any species of plant that is a controlled substance;
38 (D) testing equipment used or intended for use in identifying or in
39 analyzing the strength, effectiveness or purity of controlled substances;
40 (E) scales and balances used or intended for use in weighing or
41 measuring controlled substances;
42 (F) diluents and adulterants, including, but not limited to, quinine
43 hydrochloride, mannitol, mannite, dextrose and lactose that are used or

SB 292 8
1 intended for use in cutting controlled substances;
2 (G) separation gins and sifters used or intended for use in removing
3 twigs and seeds from or otherwise cleaning or refining marijuana;
4 (H) blenders, bowls, containers, spoons and mixing devices used or
5 intended for use in compounding controlled substances;
6 (I) capsules, balloons, envelopes, bags and other containers used or
7 intended for use in packaging small quantities of controlled substances;
8 (J) containers and other objects used or intended for use in storing or
9 concealing controlled substances;
10 (K) hypodermic syringes, needles and other objects used or intended
11 for use in parenterally injecting controlled substances into the human
12 body;
13 (L) objects used or primarily intended or designed for use in
14 ingesting, inhaling or otherwise introducing marijuana, cocaine, hashish,
15 hashish oil, phencyclidine (PCP), methamphetamine or amphetamine into
16 the human body, such as:
17 (i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with
18 or without screens, permanent screens, hashish heads or punctured metal
19 bowls;
20 (ii) water pipes, bongs or smoking pipes designed to draw smoke
21 through water or another cooling device;
22 (iii) carburetion pipes, glass or other heat-resistant tubes or any other
23 device used, intended to be used or designed to be used to cause
24 vaporization of a controlled substance for inhalation;
25 (iv) smoking and carburetion masks;
26 (v) roach clips, objects used to hold burning material, such as a
27 marijuana cigarette, that has become too small or too short to be held in
28 the hand;
29 (vi) miniature cocaine spoons and cocaine vials;
30 (vii) chamber smoking pipes;
31 (viii) carburetor smoking pipes;
32 (ix) electric smoking pipes;
33 (x) air-driven smoking pipes;
34 (xi) chillums;
35 (xii) bongs;
36 (xiii) ice pipes or chillers;
37 (xiv) any smoking pipe manufactured to disguise its intended
38 purpose;
39 (xv) wired cigarette papers; or
40 (xvi) cocaine freebase kits.
41 (3) "Drug paraphernalia" does not include:
42 (A) Any products, chemicals or materials described in K.S.A. 21-
43 5709(a), and amendments thereto; or

SB 292 9
1 (B) any materials used or intended for use to test a substance for the
2 presence of fentanyl, a fentanyl analog, ketamine or gamma
3 hydroxybutyric acid.
4 (g) "Fentanyl-related controlled substance" means any substance
5 designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b)
6 (12), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(24), (b)(26), (b)(27), (b)
7 (28), (b)(35), (b)(42), (b)(43), (b)(44), (b)(45), (b)(48), (b)(50), (b)(54), (b)
8 (55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(68), (b)(70), (b)(71), (b)(72), (b)
9 (73), (b)(74), (b)(75), (b)(76), (b)(77), (b)(78), (b)(79), (b)(80), (b)(81), (b)
10 (82), (b)(83), (b)(84), (b)(85), (b)(91), (b)(97), (b)(98), (b)(99), (b)(103),
11 (b)(104), (g)(1) or (g)(2) or 65-4107(c)(1), (c)(6), (c)(9), (c)(26), (c)(28),
12 (c)(30), (f)(3)(A) or (f)(3)(B), and amendments thereto, or any analog
13 thereof.
14 (h) "Immediate precursor" means a substance that the state board of
15 pharmacy has found to be and by rules and regulations designates as being
16 the principal compound commonly used or produced primarily for use and
17 that is an immediate chemical intermediary used or likely to be used in the
18 manufacture of a controlled substance, the control of which is necessary to
19 prevent, curtail or limit manufacture.
20 (i) "Isomer" means all enantiomers and diastereomers.
21 (j) "Manufacture" means the production, preparation, propagation,
22 compounding, conversion or processing of or placing into pill or capsule
23 form a controlled substance either directly or indirectly or by extraction
24 from substances of natural origin or independently by means of chemical
25 synthesis or by a combination of extraction and chemical synthesis.
26 "Manufacture" does not include:
27 (1) The preparation or compounding of a controlled substance by an
28 individual for the individual's own lawful use or the preparation,
29 compounding, packaging or labeling of a controlled substance:
30 (A) By a practitioner or the practitioner's agent pursuant to a lawful
31 order of a practitioner as an incident to the practitioner's administering or
32 dispensing of a controlled substance in the course of the practitioner's
33 professional practice; or
34 (B) by a practitioner or by the practitioner's authorized agent under
35 such practitioner's supervision for the purpose of or as an incident to
36 research, teaching or chemical analysis or by a pharmacist or medical care
37 facility as an incident to dispensing of a controlled substance; or
38 (2) the addition of diluents or adulterants, including, but not limited
39 to, quinine hydrochloride, mannitol, mannite, dextrose or lactose that are
40 intended for use in cutting a controlled substance.
41 (k) "Marijuana" means all parts of all varieties of the plant Cannabis
42 whether growing or not, the seeds thereof, the resin extracted from any
43 part of the plant and every compound, manufacture, salt, derivative,

SB 292 10
1 mixture or preparation of the plant, its seeds or resin. "Marijuana" does not
2 include:
3 (1) The mature stalks of the plant, fiber produced from the stalks, oil
4 or cake made from the seeds of the plant, any other compound,
5 manufacture, salt, derivative, mixture or preparation of the mature stalks,
6 except the resin extracted therefrom, fiber, oil or cake or the sterilized seed
7 of the plant that is incapable of germination;
8 (2) any substance listed in schedules II through V of the uniform
9 controlled substances act;
10 (3) drug products approved by the United States food and drug
11 administration as of the effective date of this act;
12 (4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-
13 2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
14 (5) industrial hemp as defined in K.S.A. 2-3901, and amendments
15 thereto, when cultivated, produced, possessed or used for activities
16 authorized by the commercial industrial hemp act.
17 (l) "Minor" means a person under 18 years of age.
18 (m) "Narcotic drug" means any of the following whether produced
19 directly or indirectly by extraction from substances of vegetable origin or
20 independently by means of chemical synthesis or by a combination of
21 extraction and chemical synthesis:
22 (1) Opium and opiate and any salt, compound, derivative or
23 preparation of opium or opiate;
24 (2) any salt, compound, isomer, derivative or preparation thereof that
25 is chemically equivalent or identical with any of the substances referred to
26 in paragraph (1) but not including the isoquinoline alkaloids of opium;
27 (3) opium poppy and poppy straw;
28 (4) coca leaves and any salt, compound, derivative or preparation of
29 coca leaves and any salt, compound, isomer, derivative or preparation
30 thereof that is chemically equivalent or identical with any of these
31 substances, but not including decocainized coca leaves or extractions of
32 coca leaves that do not contain cocaine or ecgonine.
33 (n) "Opiate" means any substance having an addiction-forming or
34 addiction-sustaining liability similar to morphine or being capable of
35 conversion into a drug having addiction-forming or addiction-sustaining
36 liability. "Opiate" does not include, unless specifically designated as
37 controlled under K.S.A. 65-4102, and amendments thereto, the
38 dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts
39 (dextromethorphan). "Opiate" does include its racemic and levorotatory
40 forms.
41 (o) "Opium poppy" means the plant of the species Papaver
42 somniferum l. except its seeds.
43 (p) "Person" means an individual, corporation, government or

SB 292 11
1 governmental subdivision or agency, business trust, estate, trust,
2 partnership, association or any other legal entity.
3 (q) "Poppy straw" means all parts, except the seeds, of the opium
4 poppy, after mowing.
5 (r) "School property" means property upon which is located a
6 structure used by a unified school district or an accredited nonpublic
7 school for student instruction or attendance or extracurricular activities of
8 pupils enrolled in kindergarten or any of the grades one through 12. This
9 definition shall not be construed as requiring that school be in session or
10 that classes are actually being held at the time of the offense or that
11 children must be present within the structure or on the property during the
12 time of any alleged criminal act. If the structure or property meets the
13 above definition, the actual use of that structure or property at the time
14 alleged shall not be a defense to the crime charged or the sentence
15 imposed.
16 (s) "Simulated controlled substance" means any product that
17 identifies itself by a common name or slang term associated with a
18 controlled substance and that indicates on its label or accompanying
19 promotional material that the product simulates the effect of a controlled
20 substance.
21 Sec. 5. K.S.A. 2024 Supp. 65-4101 is hereby amended to read as
22 follows: 65-4101. As used in this act:
23 (a) "Administer" means the direct application of a controlled
24 substance, whether by injection, inhalation, ingestion or any other means,
25 to the body of a patient or research subject by:
26 (1) A practitioner or pursuant to the lawful direction of a practitioner;
27 or
28 (2) the patient or research subject at the direction and in the presence
29 of the practitioner.
30 (b) "Agent" means an authorized person who acts on behalf of or at
31 the direction of a manufacturer, distributor or dispenser. "Agent" does not
32 include a common carrier, public warehouseman or employee of the carrier
33 or warehouseman.
34 (c) "Application service provider" means an entity that sells
35 electronic prescription or pharmacy prescription applications as a hosted
36 service where the entity controls access to the application and maintains
37 the software and records on its server.
38 (d) "Board" means the state board of pharmacy.
39 (e) "Bureau" means the bureau of narcotics and dangerous drugs,
40 United States department of justice, or its successor agency.
41 (f) "Controlled substance" means any drug, substance or immediate
42 precursor included in any of the schedules designated in K.S.A. 65-4105,
43 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.

SB 292 12
1 (g) (1) "Controlled substance analog" means a substance that is
2 intended for human consumption, and at least one of the following:
3 (A) The chemical structure of the substance is substantially similar to
4 the chemical structure of a controlled substance listed in or added to the
5 schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
6 thereto;
7 (B) the substance has a stimulant, depressant or hallucinogenic effect
8 on the central nervous system substantially similar to the stimulant,
9 depressant or hallucinogenic effect on the central nervous system of a
10 controlled substance included in the schedules designated in K.S.A. 65-
11 4105 or 65-4107, and amendments thereto; or
12 (C) with respect to a particular individual, such individual represents
13 or intends the substance to have a stimulant, depressant or hallucinogenic
14 effect on the central nervous system substantially similar to the stimulant,
15 depressant or hallucinogenic effect on the central nervous system of a
16 controlled substance included in the schedules designated in K.S.A. 65-
17 4105 or 65-4107, and amendments thereto.
18 (2) "Controlled substance analog" does not include:
19 (A) A controlled substance;
20 (B) a substance for which there is an approved new drug application;
21 or
22 (C) a substance with respect to which an exemption is in effect for
23 investigational use by a particular person under section 505 of the federal
24 food, drug and cosmetic act, 21 U.S.C. § 355, to the extent conduct with
25 respect to the substance is permitted by the exemption.
26 (h) "Counterfeit substance" means a controlled substance that, or the
27 container or labeling of which, without authorization bears the trademark,
28 trade name or other identifying mark, imprint, number or device or any
29 likeness thereof of a manufacturer, distributor or dispenser other than the
30 person who in fact manufactured, distributed or dispensed the substance.
31 (i) "Cultivate" means the planting or promotion of growth of five or
32 more plants that contain or can produce controlled substances.
33 (j) "DEA" means the U.S. department of justice, drug enforcement
34 administration.
35 (k) "Deliver" or "delivery" means the actual, constructive or
36 attempted transfer from one person to another of a controlled substance,
37 whether or not there is an agency relationship.
38 (l) "Dispense" means to deliver a controlled substance to an ultimate
39 user or research subject by or pursuant to the lawful order of a practitioner,
40 including the packaging, labeling or compounding necessary to prepare the
41 substance for that delivery, or pursuant to the prescription of a mid-level
42 practitioner.
43 (m) "Dispenser" means a practitioner or pharmacist who dispenses, or

SB 292 13
1 a physician assistant who has authority to dispense prescription-only drugs
2 in accordance with K.S.A. 65-28a08(b), and amendments thereto.
3 (n) "Distribute" means to deliver other than by administering or
4 dispensing a controlled substance.
5 (o) "Distributor" means a person who distributes.
6 (p) (1) "Drug" means substances:
7 (A) Recognized as drugs in the official United States pharmacopeia,
8 official homeopathic pharmacopoeia of the United States or official
9 national formulary or any supplement to any of them;
10 (B) intended for use in the diagnosis, cure, mitigation, treatment or
11 prevention of disease in human or animals;
12 (C) other than food intended to affect the structure or any function of
13 the body of human or animals; and
14 (D) intended for use as a component of any article specified in
15 subparagraph (A), (B) or (C).
16 (2) "Drug" does not include devices or their components, parts or
17 accessories.
18 (q) "Immediate precursor" means a substance that the board has
19 found to be and by rule and regulation designates as being the principal
20 compound commonly used or produced primarily for use and that is an
21 immediate chemical intermediary used or likely to be used in the
22 manufacture of a controlled substance, the control of which is necessary to
23 prevent, curtail or limit manufacture.
24 (r) "Electronic prescription" means an electronically prepared
25 prescription that is authorized and transmitted from the prescriber to the
26 pharmacy by means of electronic transmission.
27 (s) "Electronic prescription application" means software that is used
28 to create electronic prescriptions and that is intended to be installed on the
29 prescriber's computers and servers where access and records are controlled
30 by the prescriber.
31 (t) "Electronic signature" means a confidential personalized digital
32 key, code, number or other method for secure electronic data transmissions
33 that identifies a particular person as the source of the message,
34 authenticates the signatory of the message and indicates the person's
35 approval of the information contained in the transmission.
36 (u) "Electronic transmission" means the transmission of an electronic
37 prescription, formatted as an electronic data file, from a prescriber's
38 electronic prescription application to a pharmacy's computer, where the
39 data file is imported into the pharmacy prescription application.
40 (v) "Electronically prepared prescription" means a prescription that is
41 generated using an electronic prescription application.
42 (w) "Facsimile transmission" or "fax transmission" means the
43 transmission of a digital image of a prescription from the prescriber or the

SB 292 14
1 prescriber's agent to the pharmacy. "Facsimile transmission" includes, but
2 is not limited to, transmission of a written prescription between the
3 prescriber's fax machine and the pharmacy's fax machine; transmission of
4 an electronically prepared prescription from the prescriber's electronic
5 prescription application to the pharmacy's fax machine, computer or
6 printer; or transmission of an electronically prepared prescription from the
7 prescriber's fax machine to the pharmacy's fax machine, computer or
8 printer.
9 (x) "Intermediary" means any technology system that receives and
10 transmits an electronic prescription between the prescriber and the
11 pharmacy.
12 (y) "Isomer" means all enantiomers and diastereomers.
13 (z) "Manufacture" means the production, preparation, propagation,
14 compounding, conversion or processing of a controlled substance either
15 directly or indirectly or by extraction from substances of natural origin or
16 independently by means of chemical synthesis or by a combination of
17 extraction and chemical synthesis and includes any packaging or
18 repackaging of the substance or labeling or relabeling of its container,
19 except that this term does not include the preparation or compounding of a
20 controlled substance by an individual for the individual's own lawful use
21 or the preparation, compounding, packaging or labeling of a controlled
22 substance:
23 (1) By a practitioner or the practitioner's agent pursuant to a lawful
24 order of a practitioner as an incident to the practitioner's administering or
25 dispensing of a controlled substance in the course of the practitioner's
26 professional practice; or
27 (2) by a practitioner or by the practitioner's authorized agent under
28 such practitioner's supervision for the purpose of or as an incident to
29 research, teaching or chemical analysis or by a pharmacist or medical care
30 facility as an incident to dispensing of a controlled substance.
31 (aa) "Marijuana" means all parts of all varieties of the plant Cannabis
32 whether growing or not, the seeds thereof, the resin extracted from any
33 part of the plant and every compound, manufacture, salt, derivative,
34 mixture or preparation of the plant, its seeds or resin. It does not include:
35 (1) The mature stalks of the plant, fiber produced from the stalks, oil
36 or cake made from the seeds of the plant, any other compound,
37 manufacture, salt, derivative, mixture or preparation of the mature stalks,
38 except the resin extracted therefrom, fiber, oil or cake or the sterilized seed
39 of the plant that is incapable of germination;
40 (2) any substance listed in schedules II through V of the uniform
41 controlled substances act;
42 (3) drug products approved by the United States food and drug
43 administration as of the effective date of this act;

SB 292 15
1 (4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-
2 2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
3 (5) industrial hemp as defined in K.S.A. 2-3901, and amendments
4 thereto, when cultivated, produced, possessed or used for activities
5 authorized by the commercial industrial hemp act.
6 (bb) "Medical care facility" shall have the meaning ascribed to that
7 term in K.S.A. 65-425, and amendments thereto.
8 (cc) "Mid-level practitioner" means a certified nurse-midwife
9 engaging in the independent practice of midwifery under the independent
10 practice of midwifery act, an advanced practice registered nurse issued a
11 license pursuant to K.S.A. 65-1131, and amendments thereto, who has
12 authority to prescribe drugs under K.S.A. 65-1130, and amendments
13 thereto, or a physician assistant licensed under the physician assistant
14 licensure act who has authority to prescribe drugs pursuant to a written
15 agreement with a supervising physician under K.S.A. 65-28a08, and
16 amendments thereto.
17 (dd) "Narcotic drug" means any of the following whether produced
18 directly or indirectly by extraction from substances of vegetable origin or
19 independently by means of chemical synthesis or by a combination of
20 extraction and chemical synthesis:
21 (1) Opium and opiate and any salt, compound, derivative or
22 preparation of opium or opiate;
23 (2) any salt, compound, isomer, derivative or preparation thereof that
24 is chemically equivalent or identical with any of the substances referred to
25 in paragraph (1) but not including the isoquinoline alkaloids of opium;
26 (3) opium poppy and poppy straw;
27 (4) coca leaves and any salt, compound, derivative or preparation of
28 coca leaves, and any salt, compound, isomer, derivative or preparation
29 thereof that is chemically equivalent or identical with any of these
30 substances, but not including decocainized coca leaves or extractions of
31 coca leaves that do not contain cocaine or ecgonine.
32 (ee) "Opiate" means any substance having an addiction-forming or
33 addiction-sustaining liability similar to morphine or being capable of
34 conversion into a drug having addiction-forming or addiction-sustaining
35 liability. It does not include, unless specifically designated as controlled
36 under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer
37 of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). It does
38 include its racemic and levorotatory forms.
39 (ff) "Opium poppy" means the plant of the species Papaver
40 somniferum l. except its seeds.
41 (gg) "Person" means an individual, corporation, government, or
42 governmental subdivision or agency, business trust, estate, trust,
43 partnership or association or any other legal entity.

SB 292 16
1 (hh) "Pharmacist" means any natural person licensed under K.S.A.
2 65-1625 et seq., and amendments thereto, to practice pharmacy.
3 (ii) "Pharmacist intern" means: (1) A student currently enrolled in an
4 accredited pharmacy program; (2) a graduate of an accredited pharmacy
5 program serving such person's internship; or (3) a graduate of a pharmacy
6 program located outside of the United States that is not accredited and who
7 had successfully passed equivalency examinations approved by the board.
8 (jj) "Pharmacy prescription application" means software that is used
9 to process prescription information, is installed on a pharmacy's computers
10 and servers, and is controlled by the pharmacy.
11 (kk) "Poppy straw" means all parts, except the seeds, of the opium
12 poppy, after mowing.
13 (ll) "Practitioner" means a person licensed to practice medicine and
14 surgery, dentist, podiatrist, veterinarian, optometrist, or scientific
15 investigator or other person authorized by law to use a controlled
16 substance in teaching or chemical analysis or to conduct research with
17 respect to a controlled substance.
18 (mm) "Prescriber" means a practitioner or a mid-level practitioner.
19 (nn) "Production" includes the manufacture, planting, cultivation,
20 growing or harvesting of a controlled substance.
21 (oo) "Readily retrievable" means that records kept by automatic data
22 processing applications or other electronic or mechanized recordkeeping
23 systems can be separated out from all other records within a reasonable
24 time not to exceed 48 hours of a request from the board or other authorized
25 agent or that hard-copy records are kept on which certain items are
26 asterisked, redlined or in some other manner visually identifiable apart
27 from other items appearing on the records.
28 (pp) "Ultimate user" means a person who lawfully possesses a
29 controlled substance for such person's own use or for the use of a member
30 of such person's household or for administering to an animal owned by
31 such person or by a member of such person's household.
32 Sec. 6. K.S.A. 2-3908 and K.S.A. 2024 Supp. 2-3901, 21-5701 and
33 65-4101 are hereby repealed.
34 Sec. 7. This act shall take effect and be in force from and after its
35 publication in the statute book.

[DELETED: AN AT cg il h; rg to hcprhSBN0(1(2f3t4(5f6(7m8dt of ae as hg et se ss f9p0(1p2f3(4(5o6(7i8s9(0(1u2a3(4c5(6a]
[DELETED: 2((d cd p" ms an iih(a(l hd cd ps sd in a re(0(1(2(3n425(6d7i8p9p0u1(2n3(4(5(6c7a8d9(0e1(2(3(4t5(6(7(8t9(0s1(2t3(]
[DELETED: 2opmwSfb((0h1t2(9 tl c" ms t3cd e o d tl  is o4i5T6(7o8(9s0(1(2(3p4p. 5a6(7i h8d9s0h1a2dy wt b As ud in ts p, "3c" ms te se as in K. 6, a4a5(6eg in te cn or pn of il hp f7c8(930h1(2p3t]
[DELETED: 2atb(" ms an i, c, pas(KPg se u, Ft Hs se u, or ay o0a1w2(3h4(516(7g8t9w0o1(2d3s4t5a6(p e" ms a pn wo hs ad f7e8a9(0f1(2t3d4S5(6t7s8(9(0(1(2(3v]
[DELETED: 2( t ici6asc(a0h1a2c3b4i5s6(7(8(9(0i1(2(3(4(5c6(7b8rd as a hp pr pt to K. 2, a9a0d1t2e3(4(5(6(y et fm il hp wh a d7t8p9(0h1b2h3t]
[DELETED: 2t(s(s((e(0n1(2i3S4f. 5a6(7p869(0i1(2t3s4t5(6o7d8c940(1o2e3d4c546(7(8(9o0(1i2f3r]
[DELETED: 2(m(froaps0a1(2(3p4o5(6t7(8f9(0s1(2a3(4a5p6c, c, p, p, p, t7a, p, r, s, c, c8i9a0(1(2g3f4(5c6(7p8(9a0(1m2(3h]
[DELETED: 2i(t(i(i(c0(1f2b3(s ud or p id or dd fr ue i4i5h6t7(8o9b0(1t2(3d4v5(6(7m8t9(0(1(2(3(4(5(6(7(y sg pe md to de is i8p9(0(1(2(35]
[DELETED: 2(pe of f, a fl a, ke or gh(d cd s" ms a sd((((0(1(2(3t4(5p6t7t8m9p0(1(2c3f4f5s6"7(8il fr te is on ll ue or te p9c0(1o2d3p4(5s6r7f8(9t0i1(2w3p]
[DELETED: 21mi(or ce me fm te ss of te p, ay or cmeo(c0(1a2(324(5t wn c, p, pd or ud fr a6a7(8(9d0i1e2(m ad oe ad ay s, c, de o3p4(5i6i7(8(9c0t1s2c3(4a5c6l7cd ur K. 6, ad as t, t8d ir of 3n ad is s9(0f1(m p" ms te pt of te ss P2s3(" ms an i, c, gt o]
[DELETED: 21gl sn or a, bs t, e, tp(p(l p" ms p un wh is ld asspd0t1c2t3a4a5i6(d cd s" ms ay pt t7i8c9p0s1S2f3(" ms te dt an of a c4s5t6(7o8(9o0(1t2i3o4(n se p" ms an ey tt s5e6s7t8(9(0U1(2p36]
[DELETED: 21(i(tst(od0c142(3o4e5d6c748(9(0(1o2(3i4f5r6(7c8t9l0p1(2m3(4a5(" or "" ms te a, ce o6a7w8(9u0i1s2p3(]
[DELETED: 21ai(d(((on0(1p2(3t4(5s6(7a8(9f0c1ie cl i u or l to be u in t2m3p4(c p" ms an ey p5p6p7(8t9p0b1(2k3tt is a pr pn as te se of te m4a5a6(7p8e9d0(1g2(e t" or "x t" ms t3t]
[DELETED: 21pipapppp(0ts an ec pn bn te pr ad t1p2(3(4c5d6i7en ad cl ss ad is ay pg o8r9e0c1o2s3(4o5d6p7(8s9r0f1(2w3p4m5(6or ce me fm te ss of te p, ay or c7m8e9o0(1c2(3a]
[DELETED: 21(2(t wn c, p, pd or ud fr aa(t(l p" ms a cd ne0p1l2a3t4l5a6a7(8d9i0e1(m ad oe ad ay s, c, de o2p3(4i5i6(7(8c9t0s1c2(3a4c5l6u7o8i9(m p" ms te pt of te ss P0s1(" ms an i, c, g, o2gl sn or a, bs t, e, t3p]
[DELETED: 21(6(apph(t0a1(2p3(4s, d, p, v, o, or s5i o o p a l t a c6s7r8(9(0g1(2p3s4t5a6a7f8(s s 9c0o1s2S364S5p]